4.8 Article

Material-driven fibronectin assembly for high-efficiency presentation of growth factors

Journal

SCIENCE ADVANCES
Volume 2, Issue 8, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.1600188

Keywords

-

Funding

  1. European Research Council (ERC HealInSynergy) [306990]
  2. UK Medical Research Council [MR/L022710/1]
  3. Marie Curie International Outgoing Fellowship program (Protdel) [331655]
  4. NIH [R01 AR062368, R01 AR062920]
  5. BBSRC [BB/G008868/1, BB/L023814/1, BB/K006908/1] Funding Source: UKRI
  6. EPSRC [EP/G048703/1] Funding Source: UKRI
  7. MRC [MR/L022710/1] Funding Source: UKRI
  8. Biotechnology and Biological Sciences Research Council [1371511, BB/G008868/1, BB/K006908/1] Funding Source: researchfish
  9. Chief Scientist Office [CZB/4/714] Funding Source: researchfish
  10. Engineering and Physical Sciences Research Council [EP/G048703/1, 1516068] Funding Source: researchfish
  11. Medical Research Council [MR/L022710/1] Funding Source: researchfish

Ask authors/readers for more resources

Growth factors (GFs) are powerful signaling molecules with the potential to drive regenerative strategies, including bone repair and vascularization. However, GFs are typically delivered in soluble format at supraphysiological doses because of rapid clearance and limited therapeutic impact. These high doses have serious side effects and are expensive. Although it is well established that GF interactions with extracellular matrix proteins such as fibronectin control GF presentation and activity, a translation-ready approach to unlocking GF potential has not been realized. We demonstrate a simple, robust, and controlledmaterial-based approach to enhance the activity of GFs during tissue healing. The underlyingmechanism is based on spontaneous fibrillar organization of fibronectin driven by adsorption onto the polymer poly(ethyl acrylate). Fibrillar fibronectin on this polymer, but not a globular conformation obtained on control polymers, promotes synergistic presentation of integrin-binding sites and bound bone morphogenetic protein 2 (BMP-2), which enhances mesenchymal stem cell osteogenesis in vitro and drives full regeneration of a nonhealing bone defect in vivo at low GF concentrations. This simple and translatable technology could unlock the full regenerative potential of GF therapies while improving safety and cost-effectiveness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available